OBJECTIVES: Extracellular matrix (ECM) remodelling of the vessel wall is hypothesized to be an important step in atherosclerosis. Changes of the ECM are associated with the gradual progression of an atherosclerotic lesion from a lipid streak to complicated unstable plaque, leading to a complete vessel occlusion and eventually myocardial infarction (MI). Understanding of this process is critical in the treatment and prevention of ischaemic heart disease (IHD). METHODS: We investigated the histopathological characteristics of aortic wall ECM in IHD patients. Collagen I, collagen III and elastin were assessed immunohistochemically in patients with acute MI and those with stable angina, using aortic punch tissues obtained from coronary artery bypass graft surgery. Fluorescence tissue images were analysed using the tissue microarray technique. RESULTS: The results showed that collagen III expression was found to be significantly lower in the acute MI group (P < 0.001). As a result of this change, the patients with MI also revealed a significant reduction in the collagen III/collagen I ratio. The elastin/collagen III ratio was significantly higher in the MI group (P < 0.001). CONCLUSIONS: Our study provided evidence of a decrease in collagen III content in patients with MI, which could possibly explain the mechanism of plaque vulnerability and weakening of the plaque cap. A reduction in collagen III content, particularly away from the atherosclerotic lesions, might be explained by the systemic vascular changes in patients with MI, and inflammation and immune responses could be potential causes of these systemic transformations. The biochemical mechanisms and factors regulating collagen III production might be potential markers to predict possible cardiovascular events.
OBJECTIVES: Extracellular matrix (ECM) remodelling of the vessel wall is hypothesized to be an important step in atherosclerosis. Changes of the ECM are associated with the gradual progression of an atherosclerotic lesion from a lipid streak to complicated unstable plaque, leading to a complete vessel occlusion and eventually myocardial infarction (MI). Understanding of this process is critical in the treatment and prevention of ischaemic heart disease (IHD). METHODS: We investigated the histopathological characteristics of aortic wall ECM in IHD patients. Collagen I, collagen III and elastin were assessed immunohistochemically in patients with acute MI and those with stable angina, using aortic punch tissues obtained from coronary artery bypass graft surgery. Fluorescence tissue images were analysed using the tissue microarray technique. RESULTS: The results showed that collagen III expression was found to be significantly lower in the acute MI group (P < 0.001). As a result of this change, the patients with MI also revealed a significant reduction in the collagen III/collagen I ratio. The elastin/collagen III ratio was significantly higher in the MI group (P < 0.001). CONCLUSIONS: Our study provided evidence of a decrease in collagen III content in patients with MI, which could possibly explain the mechanism of plaque vulnerability and weakening of the plaque cap. A reduction in collagen III content, particularly away from the atherosclerotic lesions, might be explained by the systemic vascular changes in patients with MI, and inflammation and immune responses could be potential causes of these systemic transformations. The biochemical mechanisms and factors regulating collagen III production might be potential markers to predict possible cardiovascular events.
Authors: Birgit A Steppich; Philipp Moog; Christoph Matissek; Nicola Wisniowski; Jan Kühle; Nader Joghetaei; Franz-Josef Neumann; Albert Schomig; Ilka Ott Journal: Atherosclerosis Date: 2006-03-29 Impact factor: 5.162
Authors: Valentin Fuster; Pedro R Moreno; Zahi A Fayad; Roberto Corti; Juan J Badimon Journal: J Am Coll Cardiol Date: 2005-09-20 Impact factor: 24.094
Authors: Morteza Naghavi; Erling Falk; Harvey S Hecht; Michael J Jamieson; Sanjay Kaul; Daniel Berman; Zahi Fayad; Matthew J Budoff; John Rumberger; Tasneem Z Naqvi; Leslee J Shaw; Ole Faergeman; Jay Cohn; Raymond Bahr; Wolfgang Koenig; Jasenka Demirovic; Dan Arking; Victoria L M Herrera; Juan Badimon; James A Goldstein; Yoram Rudy; Juhani Airaksinen; Robert S Schwartz; Ward A Riley; Robert A Mendes; Pamela Douglas; Prediman K Shah Journal: Am J Cardiol Date: 2006-06-12 Impact factor: 2.778
Authors: Andrew C Newby; Sarah J George; Yasmin Ismail; Jason L Johnson; Graciela B Sala-Newby; Anita C Thomas Journal: Thromb Haemost Date: 2009-06 Impact factor: 5.249
Authors: S T Nikkari; K D O'Brien; M Ferguson; T Hatsukami; H G Welgus; C E Alpers; A W Clowes Journal: Circulation Date: 1995-09-15 Impact factor: 29.690
Authors: Nay M Htun; Dianna J Magliano; Zhen-Yu Zhang; Jasmine Lyons; Thibault Petit; Esther Nkuipou-Kenfack; Adela Ramirez-Torres; Constantin von Zur Muhlen; David Maahs; Joost P Schanstra; Claudia Pontillo; Martin Pejchinovski; Janet K Snell-Bergeon; Christian Delles; Harald Mischak; Jan A Staessen; Jonathan E Shaw; Thomas Koeck; Karlheinz Peter Journal: PLoS One Date: 2017-03-08 Impact factor: 3.240
Authors: Terri Chiong; Esther S H Cheow; Chin C Woo; Xiao Y Lin; Lay W Khin; Chuen N Lee; Mikael Hartman; Siu K Sze; Vitaly A Sorokin Journal: Open Cardiovasc Med J Date: 2016-04-27